scPharmaceuticals Inc. (SCPH) financial statements (2021 and earlier)

Company profile

Business Address 2400 DISTRICT AVENUE
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7389
Cash and cash equivalents7389
Receivables00
Prepaid expense32
Other current assets00
Total current assets:7692
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment00
Restricted cash and investments00
Other undisclosed noncurrent assets02
Total noncurrent assets:22
TOTAL ASSETS:7794
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities54
Accounts payable11
Accrued liabilities43
Debt03
Other undisclosed current liabilities 0
Total current liabilities:57
Noncurrent Liabilities
Long-term debt and lease obligation207
Long-term debt, excluding current maturities197
Operating lease, liability1
Liabilities, other than long-term debt10
Other liabilities00
Derivative instruments and hedges, liabilities1 
Other undisclosed noncurrent liabilities 1
Total noncurrent liabilities:218
Total liabilities:2615
Stockholders' equity
Stockholders' equity attributable to parent5179
Common stock00
Additional paid in capital181175
Accumulated deficit(129)(96)
Total stockholders' equity:5179
TOTAL LIABILITIES AND EQUITY:7794

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Gross profit:0 
Operating expenses(33)(30)
Other undisclosed operating loss(0) 
Operating loss:(33)(30)
Nonoperating income22
Investment income, nonoperating22
Interest and debt expense(2)(1)
Net loss available to common stockholders, diluted:(33)(29)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(33)(29)
Comprehensive loss, net of tax, attributable to parent:(33)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: